1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Acetaminophen (paracetamol, APAP) |
| brand | String | Tylenol, Panadol (international), Ofirmev (IV); huge OTC presence |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Analgesics|Non-opioid analgesic]] • [[:Category:Antipyretics|Antipyretic]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-000006A2-QINU`"', '"`UNIQ--vote-000006A3-QINU`"', '"`UNIQ--vote-000006A4-QINU`"' |
| starting_dose | String | 325-1000 mg PO every 4-6 hours as needed; maximum 4 g/d in healthy adults, 3 g/d in regular users or hepatic risk; pediatric 10-15 mg/kg every 4-6 hours |
| preparations | String | 325, 500, 650 mg tablets; 80, 160 mg chewables; 160 mg/5 mL pediatric liquid; 325 mg suppository; 1000 mg/100 mL IV (Ofirmev); fixed-dose combinations with opioids, decongestants, antihistamines |
| fda_max | String | 4 g/d in healthy adults; 3 g/d conservative limit; 2 g/d in cirrhosis or chronic alcohol use |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • rectal • IV |
| onset | String | PO: 30-60 minutes; IV: minutes |
| duration | String | 4-6 hours |
| halflife | String | 1-3 hours (normal liver); markedly prolonged in overdose with glutathione depletion'"`UNIQ--ref-000006A5-QINU`"' |
| bioavailability | String | ~85-98% (oral)'"`UNIQ--ref-000006A6-QINU`"' |
| pregnancy | String | Long the preferred analgesic-antipyretic in pregnancy; recent observational studies have raised speculative neurodevelopmental signals that remain under investigation.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | OTC and [[USLegal:Prescription only|Rx-only]] (IV, combination products) in US |
